Metabolic profiling as a tool for understanding mechanisms of toxicity.
Metabolic profiling (metabolomics/metabonomics) is the measurement in biological systems of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response to genetic modification and physiological, pathophysiological, and/or developmental stimuli. The measurement and interpretation of the endogenous metabolite profile from a biological sample (typically urine, serum, or biological tissue extract) have provided many opportunities to investigate the changes induced by external stimuli (e.g., drug treatment) or enhance our knowledge of inherent biological variation within subpopulations. This article will focus on the basic principles of metabolic profiling and how the tools (nuclear magnetic resonance [NMR], liquid chromatography-mass spectrometry [LC-MS]) can be applied in toxicology and pathology. Metabolic profiling can complement conventional methodologies and other "omics" technologies in investigating preclinical drug development issues. Case studies will illustrate the value of metabolic profiling in improving our understanding of phospholipidosis and peroxisome proliferation. A key message will be that metabolic profiling offers huge potential to highlight biomarkers and mechanisms in support of toxicology and pathology investigations in preclinical drug development.
Clarke
Christopher J
CJ
Novartis Pharma AG, Basel, Switzerland. christopher.clarke@novartis.com
Haselden
John N
JN
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D023281:Genomics; D006801:Humans; D008660:Metabolism; D010336:Pathology / Q000379:methods*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D051381:Rats; D014116:Toxicology / Q000379:methods*
D015415:Biomarkers; D004364:Pharmaceutical Preparations